Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 11, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Angio-immunoblastic T-cell lymphoma in evolution: a case report.

S Z Usmani1, T Sahay, L Eisenberg

  • 1Department of Medicine, Sinai-Grace Hospital, Detroit Medical Center, Wayne State University, Detroit, Michigan 48235, USA. saadzu@yahoo.com

Advances in Therapy
|September 29, 2007
PubMed
Summary

Angio-immunoblastic T-cell lymphoma (AITL) is a rare non-Hodgkin's lymphoma. Early diagnosis and treatment are crucial, as aggressive forms present with fever and lymphadenopathy, often leading to poor prognosis despite chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma.

Blood cancer journal·2025
Same author

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Leukemia·2017
Same author

Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma.

Journal of medical economics·2015
Same author

Insight into human protease activated receptor-1 as anticancer target by molecular modelling.

SAR and QSAR in environmental research·2015
Same author

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Bone marrow transplantation·2015
Same author

Defining and treating high-risk multiple myeloma.

Leukemia·2015

Area of Science:

  • Oncology
  • Hematology
  • Immunology

Background:

  • Angio-immunoblastic T-cell lymphoma (AITL) is a rare non-Hodgkin's lymphoma, accounting for 1-2% of cases.
  • AITL typically affects middle-aged and elderly individuals.

Observation:

  • A case study of a patient presenting with high-grade fever and lymphadenopathy is described.
  • Initial diagnostic work-up, including lymph node biopsy, was inconclusive.
  • Symptoms recurred with more pronounced lymphadenopathy, prompting further investigation.

Findings:

  • A second lymph node biopsy revealed changes suggestive of AITL.
  • Flow cytometry confirmed the diagnosis of Angio-immunoblastic T-cell lymphoma.
  • The patient achieved complete remission after the first cycle of hyper-CVAD chemotherapy.

Related Experiment Videos

Last Updated: Jul 11, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Implications:

  • AITL has a poor prognosis, particularly with standard chemotherapy regimens.
  • Physicians should consider aggressive lymphomas in patients with unexplained fever and diffuse lymphadenopathy.
  • Prompt and accurate diagnosis is critical for managing AITL and improving patient outcomes.